Halozyme Therapeutics (HALO) Tops Q2 EPS by 26c; Raises Outlook
Go back to Halozyme Therapeutics (HALO) Tops Q2 EPS by 26c; Raises Outlook| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 69.50 -1.23 (1.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $70.73 | 52 Week High | $18.39 | |||
| Open | $71.01 | 52 Week Low | $6.96 | |||
| Day High | $71.81 | P/E | N/A | |||
| Day Low | $69.32 | EPS | $-0.58 | |||
| Volume | 1,042,050 | |||||
